Foyston, Gordon, & Payne’s Genpact G Stock Holding History

Foyston, Gordon, & Payne’s Portfolio G Stock Details G Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.89M	Sell	105,090 -1,808	-2%	-$59.4K	0.62%	44
2026 Q1	$3.98M	Sell	106,898 -5,744	-5%	-$237K	0.92%	38
2025 Q4	$5.27M	Sell	112,642 -3,401	-3%	-$147K	1.15%	32
2025 Q3	$4.86M	Sell	116,043 -4,515	-4%	-$198K	1.06%	30
2025 Q2	$5.31M	Buy	120,558 +5,761	+5%	+$261K	1.21%	29
2025 Q1	$5.78M	Buy	114,797 +8,887	+8%	+$441K	1.43%	26
2024 Q4	$4.55M	Buy	105,910 +3,679	+4%	+$155K	1.2%	29
2024 Q3	$4.01M	Sell	102,231 -29,985	-23%	-$1.08M	1%	35
2024 Q2	$4.26M	Buy	+132,216	New	+$4.26M	1.05%	35

Other funds holding G

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NIEF

Nalanda India Equity Fund Mauritius $377M AUM 37.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Foyston, Gordon, & Payne's G Position: Q2 2026 in Review

Foyston, Gordon, & Payne reduced its Genpact (G) stake by 1.7% in Q2 2026, selling an estimated $59.4K and leaving 105,090 shares worth $2.89M. The position accounts for 0.62% of the portfolio, ranked #44.

Foyston, Gordon, & Payne first reported a position in G in Q2 2024 and has held it in 9 quarters since. The position peaked at $5.78M in Q1 2025. 478 funds tracked by Wall St. Rank hold G as of Q2 2026.

Foyston, Gordon, & Payne held 105,090 shares of Genpact worth $2.89M as of Q2 2026.
Foyston, Gordon, & Payne sold 1,808 Genpact shares in Q2 2026, an estimated $59.4K.
Genpact made up 0.62% of Foyston, Gordon, & Payne's portfolio in Q2 2026, its #44 holding.
Foyston, Gordon, & Payne first reported a position in Genpact in Q2 2024 and has held it in 9 quarters since.
Foyston, Gordon, & Payne's Genpact position peaked at $5.78M in Q1 2025.
478 funds tracked by Wall St. Rank held Genpact as of Q2 2026.

Based on Foyston, Gordon, & Payne's 13F filing for Q2 2026, filed 12 Aug 2026.